Skip To Main Content
Nazar Shevchuk on Muck Rack

Nazar Shevchuk

As seen in: ACS Publications
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nazar

Contact Nazar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

An End-User Audit of Reproducibility, Data Leakage, and Overfitting of the Top-Ranked ADMET Prediction Models in TDC Leaderboards Click to copy article link Article link copied!

|
By Ihor Koleiev, Roman Stratiichuk, Nazar Shevchuk
| ACS Publications
1. Introduction Click to copy section linkSection link copied! The process of novel drug development is lengthy, costly, and associated with a high risk of failure at late stages. (1,2) One of the primary reasons for attrition (accounting for up to 50% of failures) is not insufficient therapeutic efficacy, but rather unfavorable pharmacokinetic and toxicological properties, collectively referred to as ADMET (absorption, distribution, metabolism, excretion, and toxicity).
Open in Who Shared Issue with article?
See all 1 articles